Use of Dried Plasma Spots for HIV-1 Viral Load Determination and Drug Resistance Genotyping in Mexican Patients.

Journal: BioMed research international
PMID:

Abstract

Monitoring antiretroviral therapy using measurements of viral load (VL) and the genotyping of resistance mutations is not routinely performed in low- to middle-income countries because of the high costs of the commercial assays that are used. The analysis of dried plasma spot (DPS) samples on filter paper may represent an alternative for resource-limited settings. Therefore, we evaluated the usefulness of analyzing DPS samples to determine VL and identify drug resistance mutations (DRM) in a group of HIV-1 patients. The VL was measured from 22 paired plasma and DPS samples. In these samples, the average VL was 4.7 log10 copies/mL in liquid plasma and 4.1 log10 copies/mL in DPS, with a correlation coefficient of R = 0.83. A 1.1 kb fragment of HIV pol could be amplified in 14/22 (63.6%) of the DPS samples and the same value was amplified in plasma samples. A collection of ten paired DPS and liquid plasma samples was evaluated for the presence of DRM; an excellent correlation was found in the identification of DRM between the paired samples. All HIV-1 pol sequences that were obtained corresponded to HIV subtype B. The analysis of DPS samples offers an attractive alternative for monitoring ARV therapy in resource-limited settings.

Authors

  • Juan Pablo Rodriguez-Auad
    Unidad de Investigación Médica en Enfermedades Infecciosas y Parasitarias, UMAE Hospital de Pediatría, CMN Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Avenida Cuauhtémoc 330, Colonia Doctores, 06720 Mexico City, DF, Mexico; Department of Pediatric Infectious Diseases, Hospital Infantil de México Federico Gómez, Dr. Marquez 162, Colonia Doctores, 06720 Mexico City, DF, Mexico.
  • Othon Rojas-Montes
    Unidad de Investigación Médica en Enfermedades Infecciosas y Parasitarias, UMAE Hospital de Pediatría, CMN Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Avenida Cuauhtémoc 330, Colonia Doctores, 06720 Mexico City, DF, Mexico.
  • Angelica Maldonado-Rodriguez
    Unidad de Investigación Médica en Enfermedades Infecciosas y Parasitarias, UMAE Hospital de Pediatría, CMN Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Avenida Cuauhtémoc 330, Colonia Doctores, 06720 Mexico City, DF, Mexico.
  • Ma Teresa Alvarez-Muñoz
    Department of Pediatric Infectious Diseases, Hospital Infantil de México Federico Gómez, Dr. Marquez 162, Colonia Doctores, 06720 Mexico City, DF, Mexico.
  • Onofre Muñoz
    Department of Pediatric Infectious Diseases, Hospital Infantil de México Federico Gómez, Dr. Marquez 162, Colonia Doctores, 06720 Mexico City, DF, Mexico.
  • Rocio Torres-Ibarra
    Hospital de Infectología, UMAE Centro Medico Nacional "La Raza", Instituto Mexicano del Seguro Social (IMSS), Avenida Jacarandas Esquina Vallejo S/N, Colonia La Raza, 02990 Mexico City, DF, Mexico.
  • Guillermo Vazquez-Rosales
    Unidad de Investigación Médica en Enfermedades Infecciosas y Parasitarias, UMAE Hospital de Pediatría, CMN Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Avenida Cuauhtémoc 330, Colonia Doctores, 06720 Mexico City, DF, Mexico.
  • Rosalia Lira
    Unidad de Investigación Médica en Enfermedades Infecciosas y Parasitarias, UMAE Hospital de Pediatría, CMN Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Avenida Cuauhtémoc 330, Colonia Doctores, 06720 Mexico City, DF, Mexico.